Design, optimization, and in-vivo hypoglycaemic effect of nanosized glibenclamide for inhalation delivery

References

• Abadelah, M., et al. 2018. Study of the emitted dose after two separate inhalations at different inhalation flow rates and volumes and an assessment of aerodynamic characteristics of indacaterol onbrez breezhaler® 150 and 300 μg. AAPS PharmSciTech, 19 (1), 251–261.
   PubMed Web of Science ®Google Scholar
• Abdelbary, A.A., et al. 2015. Preparation, optimization, and in vitro simulated inhalation delivery of carvedilol nanoparticles loaded on a coarse carrier intended for pulmonary administration. International journal of nanomedicine, 10, 6339–6353.
   PubMed Web of Science ®Google Scholar
• Alotaibi, M.R., et al. 2019. In vivo assessment of combined effects of glibenclamide and losartan in diabetic rats. Medical principles and practice: international journal of the Kuwait University, Health Science Centre, 28 (2), 178–185.
   PubMed Web of Science ®Google Scholar
• Bendas, E.R., et al. 2013. Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus. International journal of pharmaceutics, 458 (2), 287–295.
   PubMed Web of Science ®Google Scholar
• British Pharmacopiea., 2019. Appendix XII C, Consistency of formulated preparations, aerodynamic assessment of fine particles. London, UK: MHRA.
   Google Scholar
• Buttini, F., et al. 2016. Effect of flow rate on in vitro aerodynamic performance of NEXThaler in comparison with diskus and turbohaler dry powder inhalers. Journal of aerosol medicine and pulmonary drug delivery, 29 (2), 167–178.
   PubMed Web of Science ®Google Scholar
• Carvalho, T.C., Carvalho, S.R., and McConville, J.T., 2011. Formulations for pulmonary administration of anticancer agents to treat lung malignancies. Journal of aerosol medicine and pulmonary drug delivery, 24 (2), 61–80.
   PubMed Web of Science ®Google Scholar
• Chaudhury, A., et al. 2017. Clinical review of antidiabetic drugs: implications for type 2. diabetes mellitus management. Frontiers in endocrinology, 24 (8), 6.
   Google Scholar
• Chen, Z., 2017. The use of excipients to stabilise pressurised metered dose inhalers. Dissertation. Cardiff University.
   Google Scholar
• Cirri, M., et al. 2009. Development of glyburide fast-dissolving tablets based on the combined use of cyclodextrins and polymers. Drug development and industrial pharmacy, 27, 1–10.
   Google Scholar
• De, A., et al. 2018. Smart niosomes of temozolomide for enhancement of brain targeting. Nanobiomedicine, 5,
   PubMedGoogle Scholar
• Elmowafy, E., et al. 2014. Nasal polysaccharides-glucose regulator microparticles: optimization, tolerability and antidiabetic activity in rats. Carbohydrate polymers, 108, 257–265.
   PubMed Web of Science ®Google Scholar
• El-Ridy, M.S., et al. 2011. Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin. Drug development and industrial pharmacy, 37 (12), 1491–1508.
   PubMed Web of Science ®Google Scholar
• El-Ridy, M.S., et al. 2012. Niosomes as a novel pharmaceutical formulation encapsulating the hepatoprotective drug silymarin. International journal of pharmacy and pharmaceutical sciences., 4 (1), 549–559.
   Google Scholar
• El-Say, K.M., et al. 2016. Diacerein niosomal gel for topical delivery: development, in vitro and in vivo assessment. Journal of liposome research., 26 (1), 57–68.
   PubMed Web of Science ®Google Scholar
• European Pharmacopoeia: Preparations for Inhalation., 2013. Aerodynamic assessment of fine particles. Strasbourg, France: European Directorate for Quality in Medicines and Healthcare.
   Google Scholar
• Garg, N.K., et al. 2016. Nanostructured lipid carrier mediates effective delivery of Methotrexate to induce apoptosis of rheumatoid arthritis via NF-Kb and FOXO1. International journal of pharmaceutics, 499 (1–2), 301–320.
   PubMed Web of Science ®Google Scholar
• Ge, X., et al. 2019. Advances of non-ionic surfactant vesicles (niosomes) and their application in drug delivery. Pharmaceutics, 11 (2), 55.
   PubMed Web of Science ®Google Scholar
• Goel, A., et al. 2013. Exploring targeted pulmonary delivery for treatment of lung cancer. International journal of pharmaceutical investigation, 3 (1), 8–14.
   PubMedGoogle Scholar
• Gonçalves, L.M.D., et al. 2016. Development of solid lipid nanoparticles as carriers for improving oral bioavailability of glibenclamide. European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik e.V, 102, 41–50.
   PubMed Web of Science ®Google Scholar
• Gousia Parvin, S.K., et al. 2013. Recent trends of novel drug delivery in treatment of diabetis. International journal of pharmaceutical archive, 2 (9), 224–232.
   Google Scholar
• HL, R., and Kumar G.P., 2016. Development and evaluation of polymer-bound glibenclamide oral thin film. Journal of bioequivalence & bioavailability, 09 (01), 324–330.
   Google Scholar
• Kassem, M.A., et al. 2017. Maximizing the therapeutic efficacy of imatinib mesylate-loaded niosomes on human colon adenocarcinoma using Box-Behnken design. Journal of pharmaceutical sciences, 106 (1), 111–122.
   PubMed Web of Science ®Google Scholar
• Kumar, S., et al. 2015. Biocompatible PLGA-oil hybrid nanoparticles for high loading and controlled delivery of resveratrol. Journal of drug delivery science and technology, 30, 54–62.
   Web of Science ®Google Scholar
• Lucio, D., et al. 2017. Nanoaggregation of inclusion complexes of glibenclamide with cyclodextrins. International journal of pharmaceutics, 519 (1–2), 263–271.
   PubMed Web of Science ®Google Scholar
• Marianecci, C., et al. 2014. Ammonium glycyrrhizinate-loaded niosomes as a potential nanotherapeutic system for anti-inflammatory activity in murine models. International journal of nanomedicine, 9, 635–651.
   PubMed Web of Science ®Google Scholar
• Masarudin, M.J., et al. 2015. Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14C]-doxorubicin. Nanotechnology, science and applications journal, 8, 67–80.
   PubMed Web of Science ®Google Scholar
• Morakul, B., Teeranachaideekul, V., and Junyaprasert, V.B., 2019. Niosomal delivery of pumpkin seed oil: development, characterisation, and physical stability. Journal of microencapsulation, 36 (2), 120–129.
   PubMed Web of Science ®Google Scholar
• Mura, P., et al. 2012. New solid self-microemulsifying systems to enhance dissolution rate of poorly water soluble drugs. Pharmaceutical development and technology, 17 (3), 277–284.
   PubMed Web of Science ®Google Scholar
• Myrdal, P.B., Sheth, P., and Stein, S.W., 2013. The influence of initial atomized droplet size on residual particle size from pressurized metered dose inhalers. International journal of pharmaceutics, 455 (1–2), 57–65.
   PubMed Web of Science ®Google Scholar
• Nathan, D.M., et al. 2008. Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy update regarding the thiazolidinediones. Diabetologia, 51 (1), 8–11.
   PubMed Web of Science ®Google Scholar
• Nowroozi, F., et al. 2018. Effect of surfactant type, cholesterol content and various downsizing methods on the particle size of niosomes. Iranian journal of pharmaceutical research, 17 (2), 1–11.
   PubMedGoogle Scholar
• Roche, N., et al. 2013. Effectiveness of inhaler devices in adult asthma and COPD. European medical journal-respiratory, 1, 64–71.
   Google Scholar
• Sakthivel, M., et al. 2012. Formulation and in vitro evaluation of niosomes containing oxcarbazepine. International journal of pharmacy and pharmaceutical sciences, 4 (3), 563–567.
   Google Scholar
• Seleci, D.A., et al. 2016. Niosomes as nanoparticular drug carriers: fundamentals and recent applications. Journal of nanomaterials, 2016, 1–13.
   Web of Science ®Google Scholar
• Shah, S.R., et al. 2013. Application of Plackett–Burman screening design for preparing glibenclamide nanoparticles for dissolution enhancement. Powder technology., 235, 405–411.
   Web of Science ®Google Scholar
• Singh, A.P., et al. 2019. Signal targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles. Transduction and targeted therapy, 4, 33.
   PubMed Web of Science ®Google Scholar
• Singh, C.H., Jain, C.P., and Kumar, B.N., 2011. Formulation, characterization, stability and in-vitro evaluation of Nimesulide niosomes. Pharmacophore journal, 2 (3), 168–185.
   Google Scholar
• USP/NF. 2016. Inhalation and nasal drug products: aerosols, sprays, and powders—performance quality tests. U.S. Pharmacopeia National Formulary. 39 ed. Rockville, MD: Pharmacopeial Convention, Inc.
   Google Scholar
• Vadlamudi, H.C., et al. 2014. Formulation and pharmacodynamic evaluation of glibenclamide incorporated niosomal gel. Current drug discovery technologies, 11 (3), 189–196.
   PubMedGoogle Scholar
• Williams, J., 2007. Handbook for cleaning/decontamination of surfaces, formulation of carpet cleaners. Elsevier Science.
   Google Scholar
• Yeom, S., Shin, B.S., and Han, S., 2014. An electron spin resonance study of non-ionic surfactant vesicles (niosomes). Chemistry and physics of lipids, 181, 83–89.
   PubMed Web of Science ®Google Scholar
• Zidan, A.S., Ibrahim, M.M., and El Megrab, N.A., 2017. Optimization of methotrexate loaded niosomes by Box-Behnken design: an understanding of solvent effect and formulation variability. Drug development and industrial pharmacy, 43 (9), 1450–1459.
   PubMed Web of Science ®Google Scholar